BPS Bioscience Inc.
中级会员 | 第3年

当前位置:BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 78557TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line

TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line

参  考  价面议
具体成交价以合同协议为准

产品型号78557

品       牌BPS Bioscience

厂商性质生产商

所  在  地

更新时间:2023-11-11 19:29:23浏览次数:240次

联系我时,请告知来自 化工仪器网
同类优质产品更多>
●Purchase●DescriptionThiscelllineisadoubleknockoutofTCR(TCellReceptor)andB2M(Beta-2-Microglobulin)
Purchase
Description

This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells to generate the TCR Knockout NFAT Luciferase Reporter Jurkat cell Line (BPS Bioscience #78556). These TCR knockout cells were used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing.

Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
Beta-2-microglobulin, B2M, CDABP0092, HDCMA22P

会员登录

×

请输入账号

请输入密码

=

请输验证码

收藏该商铺

X
该信息已收藏!
标签:
保存成功

(空格分隔,最多3个,单个标签最多10个字符)

常用:

提示

X
您的留言已提交成功!我们将在第一时间回复您~
拨打电话
在线留言